2022 Speakers

Adrian Hobson

Senior Research Fellow, Drug Discovery Science & Technology Antibody-Drug Conjugates

AbbVie

Jin-Chen Yu

Senior Vice President, Preclinical Research

Bio-Thera Solutions

Nicolas Camper

Group Leader & Bioconjugate Chemistry

Abzena

Yu Shen

Director, Oncology Discovery

AbbVie

John Boylan

Vice President, Scientific Strategy

Exelixis

John Lambert

Consultant

Attager Consulting

Rakesh Dixit

Chief Executive Officer

Bionavigen

Sayumi Yamazoe

Senior Principal Scientist

Bristol-Myers Squibb

Anikó Pálfi

Director, Biochemistry & Cell Biology

Heidelberg Pharma Research GmbH

Christopher Shelton

Scientific Director, Tumor Cell Targeting Research Unit

GlaxoSmithKline

Hanspeter Gerber

Chief Scientific Officer

Codeable Therapeutics

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Dowdy Jackson

Executive Director, ADC Biology Research

Innovent Biologics

John DaSilva

Associate Director, Oncology & Immuno-Oncology

Regeneron

Robert Lawrence

Senior Scientist

Seagen

Thomas Nittoli

Senior Director, R&D Chemistry

Regeneron

Annette Vogl

Director, Biology & Translational Research

Tubulis GmbH

Daniele Biasci

Consulting VP, Immunology

Absci

John Boylan

Vice President, Scientific Strategy

Exelixis

Laurence Madera

Senior Scientist

Zymeworks

Mark Gustavson

Senior Director, Oncology Translational Medicine

AstraZeneca